恒瑞医药(01276)11月4日斥资1302.21万元回购21万股A股

Core Viewpoint - Heng Rui Medicine (01276) announced a share buyback plan, intending to repurchase 210,000 A-shares at a total cost of 13.0221 million yuan [1] Group 1 - The company plans to execute the buyback on November 4, 2025 [1] - The total expenditure for the buyback is approximately 13.0221 million yuan [1] - The number of shares to be repurchased is 210,000 [1]